Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2017)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - EERP ; DUARTE, GERALDO - FMRP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1038/tpj.2016.35
- Subjects: POLIMORFISMO; FÁRMACOS (SISTEMA CARDIOVASCULAR); HIPERTENSÃO NA GRAVIDEZ
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 17, n. 5, p. 427-434, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LUIZON, Marcelo Rizzatti et al. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 17, n. 5, p. 427-434, 2017Tradução . . Disponível em: https://doi.org/10.1038/tpj.2016.35. Acesso em: 23 abr. 2024. -
APA
Luizon, M. R., Palei, A. C. T., Belo, V. A., Amaral, L. M., Lacchini, R., Duarte, G., et al. (2017). Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 17( 5), 427-434. doi:10.1038/tpj.2016.35 -
NLM
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1038/tpj.2016.35 -
Vancouver
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1038/tpj.2016.35 - Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy
- Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- ENOS tagging SNP haplotypes in hypertensive disorders of pregnancy
- Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy
- NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia
- eNOS tag SNP haplotypes in hypertensive disorders of pregnancy
- Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia
- Características clínicas e laboratoriais de gestantes com pré-eclâmpsia versus hipertensão gestacional
- Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia
Informações sobre o DOI: 10.1038/tpj.2016.35 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
